Key facts
- It has raised $9.7M; the latest was Early Stage VC ($9.7M) in Nov 2025.
- Notable investors include Tech Incubator Program for Startup, KAIC TO Ventures, Mirae Science and Technology, TBIC KAIST.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Barreleye
- ·The full record, as it builds
Funding rounds
No funding rounds for Barreleye are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Barreleye
Developer of a medical technology powered by an ultrasound AI machine designed to discover features of advanced ultrasound systems. The company offers devices that can extract quantitative values of human tissue using artificial intelligence technology, adding value for both clinicians and patients alike, enabling health professionals to maximize diagnostic performance and systematically manage the patient's health.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2021
- Employees
- 15
- Website
- barreleye.co.kr/
- Ownership
- Privately Held (backing)
Barreleye doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Barreleye shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Barreleye in its N-PORT filings yet. We sweep new filings monthly.